Aperio expands operations to Australia, New Zealand
Aperio Technologies has opened an Australian and New Zealand operations center, headquartered in Brisbane, Australia.
The expansion, bolstered by increasing demand for the company’s digital pathology solutions, will be led by Howard Powell, national sales director, and will focus on providing sales, service and marketing support across Australia and New Zealand, the company said.
Dirk Soenksen, CEO of Aperio, said that the company’s digital pathology solutions enable users to improve workflow processes and expanding data access, integration and reporting capabilities. Aperio’s patented linear array-based ScanScope slide scanning systems are offered with Spectrum information management software to enable the viewing, analysis and management of digital slides and other images in a secure multi-user, multi-site environment, from anywhere, anytime, he said.
Aperio currently has an installed base of more than 375 systems in 25 countries, including more than two-thirds of the top 15 rated U.S. hospitals, leading academic medical centers and reference laboratories, and two-thirds of the top 15 pharmaceutical companies, the company said.
The expansion, bolstered by increasing demand for the company’s digital pathology solutions, will be led by Howard Powell, national sales director, and will focus on providing sales, service and marketing support across Australia and New Zealand, the company said.
Dirk Soenksen, CEO of Aperio, said that the company’s digital pathology solutions enable users to improve workflow processes and expanding data access, integration and reporting capabilities. Aperio’s patented linear array-based ScanScope slide scanning systems are offered with Spectrum information management software to enable the viewing, analysis and management of digital slides and other images in a secure multi-user, multi-site environment, from anywhere, anytime, he said.
Aperio currently has an installed base of more than 375 systems in 25 countries, including more than two-thirds of the top 15 rated U.S. hospitals, leading academic medical centers and reference laboratories, and two-thirds of the top 15 pharmaceutical companies, the company said.